For a country bent on healthcare cost control, findings represent an opportunity: authors say nearly 8% of the nation’s total outlay could have been avoided.
GlaxoSmithKline’s Dierdre Connelly peeled back the curtain on the company’s sales force incentives revamp in a speech to the Pharmaceutical Regulatory and Compliance Congress, and pleaded for recognition that the industry had cleaned up the sketchy practices of the Blockbuster Era.
Pharma’s med/legal/regulatory (MLR) teams, managers of risk and so often the scapegoats for creating roadblocks to digital innovation, were discussed in a much friendlier light by digital marketers at last week’s ExL Digital Pharma East conference in Philadelphia.
GSK seeks to span digital divide with social/digital dragnet
GlaxoSmithKline is souping up its social media monitoring with a digital strategy it says will create processes that are standard enough to streamline communications, but flexible enough to meet local requirements.
GSK hopes $3-bil. off-label settlement will end legal woes
GlaxoSmithKline’s deal to resolve multiple US investigations into its sales and marketing practices—one of the largest settlements by a pharma company—aims to patch up several long-running legal disputes.
Omnicom, CAHG sign up for regulatory compliance training
Agency CAHG became the first healthcare marketing shop to undergo training and certification in regulatory compliance through the Center for Communication Compliance, and its parent company, Omnicom, said all of its healthcare agencies will follow suit.
Asking consumers to gauge their risk for non-adherence, Merck is deploying a one-minute survey dubbed the Adherence Estimator that may be the way forward for keeping patients on-treatment.
Majority of pharma journal ads not FDA-compliant: study
Four out of five ads analyzed in a study of physician-directed pharmaceutical advertising would definitely not pass FDA muster, or might have trouble doing so, said researchers. Their findings may have implications for the FDA, DDMAC and the “Bad Ad” program.